Targeted Correction of Single-Base-Pair Mutations with Adeno-Associated Virus Vectors under Nonselective Conditions

Journal of Virology

Volumn 78, Issue 8, 2004, Pages 4165-4175

  Liu, Xiaoming ^a   Yan, Ziying ^a   Luo, Meihui ^a   Zak, Roman ^a   Li, Ziyi ^a   Driskell, Ryan R ^a   Huang, Yumao ^a   Tran, Nam ^a   Engelhardt, John F ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; GREEN FLUORESCENT PROTEIN; PARVOVIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ARTICLE; BASE PAIRING; CELL CYCLE G1 PHASE; CELL SUBPOPULATION; FIBROBLAST; GENE EXPRESSION REGULATION; GENE MUTATION; GENE TARGETING; GENE THERAPY; GENETIC RECOMBINATION; GENOTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TARGET CELL; TRANSGENE; VIRUS GENOME; VIRUS INFECTION; VIRUS RECOMBINANT;

ANIMALS; BASE SEQUENCE; CELL LINE; DEPENDOVIRUS; DNA REPAIR; DNA, RECOMBINANT; GENE TARGETING; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; LUMINESCENT PROTEINS; MICE; MICE, TRANSGENIC; MODELS, GENETIC; POINT MUTATION; RECOMBINANT PROTEINS; RECOMBINATION, GENETIC; S PHASE;

EID: 1842484129     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.8.4165-4175.2004     Document Type: Article

References (52)

1. Alexander, I. E., D. W. Russell, and A. D. Miller. 1994. DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors. J. Virol. 68:8282-8287.
2. Alexander, I. E., D. W. Russell, A. M. Spence, and A. D. Miller. 1996. Effects of gamma irradiation on the transduction of dividing and nondividing cells in brain and muscle of rats by adeno-associated virus vectors. Hum. Gene Ther. 7:841-850.
3. Alexeev, V., and K. Yoon. 2000. Gene correction by RNA-DNA oligonucleotides. Pigment Cell Res. 13:72-79.
4. Bandyopadhyay, P., X. Ma, C. Linehan-Stieers, B. T. Kren, and C. J. Steer. 1999. Nucleotide exchange in genomic DNA of rat hepatocytes using RNA/ DNA oligonucleotides. Targeted delivery of liposomes and polyethyleneimine to the asialoglycoprotein receptor. J. Biol. Chem. 274:10163-10172.
5. Bartlett, R. J., S. Stockinger, M. M. Denis, W. T. Bartlett, L. Inverardi, T. T. Le, N. Thi Man, G. E. Morris, D. J. Bogan, J. Metcalf-Bogan, and J. N. Kornegay. 2000. In vivo targeted repair of a point mutation in the canine dystrophin gene by a chimeric RNA/DNA oligonucleotide. Nat. Biotechnol. 18:615-622.
6. Bertoni, C., and T. A. Rando. 2002. Dystrophin gene repair in mdx muscle precursor cells in vitro and in vivo mediated by RNA-DNA chimeric oligonucleotides. Hum. Gene Ther. 13:707-718.
7. Bonifacino, J. S. 1998. Current protocols in cell biology. John Wiley, New York, N.Y.
8. Brown, K. D., A. Rathi, R. Kamath, D. I. Beardsley, Q. Zhan, J. L. Mannino, and R. Baskaran. 2003. The mismatch repair system is required for S-phase checkpoint activation. Nat. Genet. 33:80-84.
9. Chan, P. P., M. Lin, A. F. Faruqi, J. Powell, M. M. Seidman, and P. M. Glazer. 1999. Targeted correction of an episomal gene in mammalian cells by a short DNA fragment tethered to a triplex-forming oligonucleotide. J. Biol. Chem. 274:11541-11548.
10. Cole-Strauss, A., K. Yoon, Y. Xiang, B. C. Byrne, M. C. Rice, J. Gryn, W. K. Holloman, and E. B. Kmiec. 1996. Correction of the mutation responsible for sickle cell anemia by an RNA-DNA oligonucleotide. Science 273:1386-1389.
11. Colosimo, A., K. K. Goncz, G. Novelli, B. Dallapiccola, and D. C. Gruenert. 2001. Targeted correction of a defective selectable marker gene in human epithelial cells by small DNA fragments. Mol. Ther. 3:178-185.
12. Culver, K. W., W. T. Hsieh, Y. Huyen, V. Chen, J. Liu, Y. Khripine, and A. Khorlin. 1999. Correction of chromosomal point mutations in human cells with bifunctional oligonucleotides. Nat. Biotechnol. 17:989-993.
13. Debelak, D., J. Fisher, S. Iuliano, D. Sesholtz, D. L. Sloane, and E. M. Atkinson. 2000. Cation-exchange high-performance liquid chromatography of recombinant adeno-associated virus type 2. J. Chromatogr. B 740:195-202.
14. Ding, W., Z. Yan, R. Zak, M. Saavedra, D. M. Rodman, and J. F. Engelhardt. 2003. Second strand genome conversion of AAV-2 and AAV-5 is not rate limiting following apical infection of polarized human airway epithelia. J. Virol. 77:7361-7366.
15. Drittanti, L., C. Jenny, K. Poulard, A. Samba, P. Manceau, N. Soria, N. Vincent, O. Danos, and M. Vega. 2001. Optimised helper virus-free production of high-quality adeno-associated virus vectors. J. Gene Med. 3:59-71.
16. Duan, D., P. Sharma, J. Yang, Y. Yue, L. Dudus, Y. Zhang, K. J. Fisher, and J. F. Engelhardt. 1998. Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue. J. Virol. 72:8568-8577.
17. Duan, D., Z. Yan, Y. Yue, W. Ding, and J. F. Engelhardt. 2001. Enhancement of muscle gene delivery with pseudotyped adeno-associated virus type 5 correlates with myoblast differentiation. J. Virol. 75:7662-7671.
18. Duan, D., Y. Yue, Z. Yan, P. B. McCray, Jr., and J. F. Engelhardt. 1998. Polarity influences the efficiency of recombinant adeno-associated virus infection in differentiated airway epithelia. Hum. Gene Ther. 9:2761-2776.
19. Duan, D., Y. Yue, Z. Yan, J. Yang, and J. F. Engelhardt. 2000. Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus. J. Clin. Investig. 105:1573-1587.
20. Goncz, K. K., A. Colosimo, B. Dallapiccola, L. Gagne, K. Hong, G. Novelli, D. Papahadjopoulos, T. Sawa, H. Schreier, J. Wiener-Kronish, Z. Xu, and D. C. Gruenert. 2001. Expression of deltaF508 CFTR in normal mouse lung after site-specific modification of CFTR sequences by SFHR. Gene Ther. 8:961-965.
21. Goncz, K. K., N. L. Prokopishyn, B. L. Chow, B. R. Davis, and D. C. Gruenert. 2002. Application of SFHR to gene therapy of monogenic disorders. Gene Ther. 9:691-694.
22. Graham, I. R., and G. Dickson. 2002. Gene repair and mutagenesis mediated by chimeric RNA-DNA oligonucleotides: chimeraplasty for gene therapy and conversion of single nucleotide polymorphisms (SNPs). Biochim. Biophys. Acta 1587:1-6.
23. Hansen, J., K. Qing, H. J. Kwon, C. Mah, and A. Srivastava. 2000. Impaired intracellular trafficking of adeno-associated virus type 2 vectors limits efficient transduction of murine fibroblasts. J. Virol. 74:992-996.
24. Hansen, J., K. Qing, and A. Srivastava. 2001. Adeno-associated virus type 2-mediated gene transfer: altered endocytic processing enhances transduction efficiency in murine fibroblasts. J. Virol. 75:4080-4090.
25. Hirata, R., J. Chamberlain, R. Dong, and D. W. Russell. 2002. Targeted transgene insertion into human chromosomes by adeno-associated virus vectors. Nat. Biotechnol. 20:735-738.
26. Hirata, R. K., and D. W. Russell. 2000. Design and packaging of adeno-associated virus gene targeting vectors. J. Virol. 74:4612-4620.
27. Igoucheva, O., V. Alexeev, and K. Yoon. 2002. Nuclear extracts promote gene correction and strand pairing of oligonucleotides to the homologous plasmid. Antisense Nucleic Acid Drug Dev. 12:235-246.
28. Igoucheva, O., V. Alexeev, and K. Yoon. 2001. Targeted gene correction by small single-stranded oligonucleotides in mammalian cells. Gene Ther. 8:391-399.
29. Inoue, N., R. Dong, R. K. Hirata, and D. W. Russell. 2001. Introduction of single base substitutions at homologous chromosomal sequences by adeno-associated virus vectors. Mol. Ther. 3:526-530.
30. Inoue, N., R. K. Hirata, and D. W. Russell. 1999. High-fidelity correction of mutations at multiple chromosomal positions by adeno-associated virus vectors. J. Virol. 73:7376-7380.
31. Inoue, N., and D. W. Russell. 1998. Packaging cells based on inducible gene amplification for the production of adeno-associated virus vectors. J. Virol. 72:7024-7031.
32. Kaludov, N., B. Handelman, and J. A. Chiorini. 2002. Scalable purification of adeno-associated virus type 2, 4, or 5 using ion-exchange chromatography. Hum. Gene Ther. 13:1235-1243.
33. Matsushita, T., S. Elliger, C. Elliger, G. Podsakoff, L. Villarreal, G. J. Kurtzman, Y. Iwaki, and P. Colosi. 1998. Adeno-associated virus vectors can be efficiently produced without helper virus. Gene Ther. 5:938-945.
34. Miller, D. G., L. M. Petek, and D. W. Russell. 2003. Human gene targeting by adeno-associated virus vectors is enhanced by DNA double-strand breaks. Mol. Cell. Biol. 23:3550-3557.
35. Nam, D., X. L. Tran, Z. Yan, D. Abbote, Q. Jiang, E. B. Kmiec, C. D. Sigmunt, and J. F. Engelhardt. 2003. Efficiency of chimeraplast gene targeting by direct nuclear injection using a GFP recovery assay. Mol. Ther. 7:248-253.
36. Porteus, M. H., T. Cathomen, M. D. Weitzman, and D. Baltimore. 2003. Efficient gene targeting mediated by adeno-associated virus and DNA double-strand breaks. Mol. Cell. Biol. 23:3558-3565.
37. Prasad, K. M., and J. P. Trempe. 1995. The adeno-associated virus Rep78 protein is covalently linked to viral DNA in a preformed virion. Virology 214:360-370.
38. Qing, K., C. Mah, J. Hansen, S. Zhou, V. Dwarki, and A. Srivastava. 1999. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat. Med. 5:71-77.
39. Rando, T. A., M. H. Disatnik, and L. Z. Zhou. 2000. Rescue of dystrophin expression in mdx mouse muscle by RNA/DNA oligonucleotides. Proc. Natl. Acad. Sci. USA 97:5363-5368.
40. Richardson, P. D., B. T. Kren, and C. J. Steer. 2002. Gene repair in the new age of gene therapy. Hepatology 35:512-518.
41. Russell, D. W., I. E. Alexander, and A. D. Miller. 1995. DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors. Proc. Natl. Acad. Sci. USA 92:5719-5723.
42. Russell, D. W., and R. K. Hirata. 1998. Human gene targeting by viral vectors. Nat. Genet. 18:325-330.
43. Russell, D. W., R. K. Hirata, and N. Inoue. 2002. Validation of AAV-mediated gene targeting. Nat. Biotechnol. 20:658.
44. Russell, D. W., A. D. Miller, and I. E. Alexander. 1994. Adeno-associated virus vectors preferentially transduce cells in S phase. Proc. Natl. Acad. Sci. USA 91:8915-8919.
45. Sanlioglu, S., P. Benson, and J. F. Engelhardt. 2000. Loss of ATM function enhances recombinant adeno-associated virus transduction and integration through pathways similar to UV irradiation. Virology 268:68-78.
46. Sanlioglu, S., D. Duan, and J. F. Engelhardt. 1999. Two independent molecular pathways for recombinant adeno-associated virus genome conversion occur after UV-C and E4orf6 augmentation of transduction. Hum. Gene Ther. 10:591-602.
47. Thorpe, P. H., B. J. Stevenson, and D. J. Porteous. 2002. Functional correction of episomal mutations with short DNA fragments and RNA-DNA oligonucleotides. J. Gene Med. 4:195-204.
48. Wassarman, P. M., and M. L. DePamphilis. 1993. Guide to techniques in mouse development. Academic Press, San Diego, Calif.
49. Winters, T. A. 2000. Gene targeted agents: new opportunities for rational drug development. Curr. Opin. Mol. Ther. 2:670-681.
50. Xiao, X., J. Li, and R. J. Samulski. 1998. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. 72:2224-2232.
51. Yan, Z., R. Zak, G. W. Luxton, T. C. Ritchie, U. Bantel-Schaal, and J. F. Engelhardt. 2002. Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors. J. Virol. 76:2043-2053.
52. Yan, Z., Y. Zhang, D. Duan, and J. F. Engelhardt. 2000. Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy. Proc. Natl. Acad. Sci. USA 97:6716-6721.